SUBSCRIBE
SUBSCRIBE
News   Business

Helicon Group Secures Exclusive China Rights For Collatamp G, An Innovative Drug Release Surgical Implant

May 12, 2008 | 
1 min read

Perth, May 12, 2008 (ABN Newswire) - HELICON GROUP LIMITED (ASX: HCG) announced today that it had acquired the exclusive licensing rights from EUSA Pharma to Collatamp(R) G for the Chinese market.

Alliances Australia
MORE ON THIS TOPIC
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel
Correct decision chosing - confused man character standing on the crossroads and looking at signpost with three different directions - conceptual vector illustration
Depression
Relmada Considering ‘Strategic Alternatives’ After Failure of Depression Asset
December 9, 2024
 · 
1 min read
 · 
Heather McKenzie
Pictured: Eli Lilly's biotechnology center in California
Manufacturing
Lilly Pumps $3B Into Wisconsin Site as Compounders Close In on Tirzepatide
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac